Karolína Perglerová

524 total citations
15 papers, 256 citations indexed

About

Karolína Perglerová is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Karolína Perglerová has authored 15 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Karolína Perglerová's work include Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Karolína Perglerová is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Karolína Perglerová collaborates with scholars based in Germany, Czechia and Switzerland. Karolína Perglerová's co-authors include Claudia Haferlach, Wolfgang Kern, Torsten Haferlach, Susanne Schnittger, Anna Stengel, Dominic Rose, Tamara Alpermann, Melanie Zenger, Ursula Creutzig and Christine von Neuhoff and has published in prestigious journals such as Blood, Cancer and British Journal of Haematology.

In The Last Decade

Karolína Perglerová

14 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karolína Perglerová Germany 6 194 109 91 63 37 15 256
Melanie Zenger Germany 9 247 1.3× 80 0.7× 120 1.3× 103 1.6× 26 0.7× 29 335
Mahesh Swaminathan United States 8 172 0.9× 111 1.0× 81 0.9× 30 0.5× 26 0.7× 31 239
M-C. Kuo Taiwan 6 321 1.7× 164 1.5× 155 1.7× 57 0.9× 27 0.7× 9 377
Michaël Broux Belgium 6 114 0.6× 128 1.2× 30 0.3× 125 2.0× 47 1.3× 6 277
Ina Stolze Germany 4 316 1.6× 201 1.8× 124 1.4× 80 1.3× 33 0.9× 6 392
Teresa Sadras Australia 10 107 0.6× 150 1.4× 39 0.4× 66 1.0× 61 1.6× 22 301
Bartlomiej Getta United States 6 184 0.9× 64 0.6× 117 1.3× 54 0.9× 37 1.0× 19 236
C. Troff Germany 7 224 1.2× 77 0.7× 91 1.0× 78 1.2× 14 0.4× 13 301
Sally Jeffries United Kingdom 6 183 0.9× 66 0.6× 57 0.6× 50 0.8× 58 1.6× 10 235
Samuel Quentin France 7 182 0.9× 132 1.2× 87 1.0× 41 0.7× 34 0.9× 9 288

Countries citing papers authored by Karolína Perglerová

Since Specialization
Citations

This map shows the geographic impact of Karolína Perglerová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolína Perglerová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolína Perglerová more than expected).

Fields of papers citing papers by Karolína Perglerová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolína Perglerová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolína Perglerová. The network helps show where Karolína Perglerová may publish in the future.

Co-authorship network of co-authors of Karolína Perglerová

This figure shows the co-authorship network connecting the top 25 collaborators of Karolína Perglerová. A scholar is included among the top collaborators of Karolína Perglerová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolína Perglerová. Karolína Perglerová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Stengel, Anna, Wolfgang Kern, Manja Meggendorfer, et al.. (2017). Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML. Leukemia. 32(2). 295–302. 27 indexed citations
2.
Haferlach, Torsten, Tamara Alpermann, Karolína Perglerová, et al.. (2016). Feasibility of BAALC gene expression for detection of minimal residual disease and risk stratification in normal karyotype acute myeloid leukaemia. British Journal of Haematology. 175(5). 904–916. 10 indexed citations
3.
Fasan, Annette, Claudia Haferlach, Karolína Perglerová, Wolfgang Kern, & Torsten Haferlach. (2016). CSF3R Mutations Are Predominantly Subclonal Events in Intermediate Risk Karyotype AML and Prevalently Occur with CEBPA Mutations. Blood. 128(22). 1658–1658. 1 indexed citations
4.
Rose, Dominic, Torsten Haferlach, Susanne Schnittger, et al.. (2016). Subtype-specific patterns of molecular mutations in acute myeloid leukemia. Leukemia. 31(1). 11–17. 64 indexed citations
5.
6.
Meggendorfer, Manja, Sabine Jeromin, Karolína Perglerová, et al.. (2016). SF3B1 Mutations in AML, MDS and MDS/MPN-RS-T Are Accompanied By Different Other Gene Mutations: Impact for Targeted Treatment Studies. Blood. 128(22). 1976–1976. 1 indexed citations
7.
Creutzig, Ursula, Martin Zimmermann, Dirk Reinhardt, et al.. (2016). Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups. Cancer. 122(24). 3821–3830. 76 indexed citations
8.
Jeromin, Sabine, Alexander Kohlmann, Manja Meggendorfer, et al.. (2015). Next-generation deep-sequencing detects multiple clones of CALR mutations in patients with BCR-ABL1 negative MPN. Leukemia. 30(4). 973–976. 9 indexed citations
9.
Stengel, Anna, Wolfgang Kern, Melanie Zenger, et al.. (2015). Genetic characterization of T‐PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker. Genes Chromosomes and Cancer. 55(1). 82–94. 54 indexed citations
10.
11.
Schnittger, Susanne, Claudia Haferlach, Niroshan Nadarajah, et al.. (2014). In AML Secondary to MDS NPM1 Mutations Are Late Events, Less Frequent, and Associated with a Different Pattern of Molecular Mutations Than in De Novo AML. Blood. 124(21). 700–700. 4 indexed citations
12.
Schnittger, Susanne, Claudia Haferlach, Tamara Alpermann, et al.. (2014). DNMT3A is a Powerful Follow-up Marker in NPM1 mutated AML. Blood. 124(21). 122–122. 3 indexed citations
13.
Rose, Dominic, Torsten Haferlach, Susanne Schnittger, et al.. (2014). Specific Patterns of Molecular Mutations Determine the Morphologic Differentiation Stages in Acute Myeloid Leukemia (AML). Blood. 124(21). 2388–2388. 2 indexed citations
14.
Meggendorfer, Manja, Tamara Alpermann, Karolína Perglerová, et al.. (2014). Genetic Patterns of Relapsed AML Differ Significantly from First Manifestation and Are Dependent on Cytogenetic Risk Groups at Diagnosis: Results in 175 Patients with Paired Samples. Blood. 124(21). 1029–1029. 3 indexed citations
15.
Koudová, Monika, et al.. (2014). Frequency of the DPYD * 2A allele in the Czech population. The EPMA Journal. 5(S1).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Zenger Breakdown of academic impact, for papers by Mahesh Swaminathan Breakdown of academic impact, for papers by M-C. Kuo Breakdown of academic impact, for papers by Michaël Broux Breakdown of academic impact, for papers by Ina Stolze Breakdown of academic impact, for papers by Teresa Sadras Breakdown of academic impact, for papers by Bartlomiej Getta Breakdown of academic impact, for papers by C. Troff Breakdown of academic impact, for papers by Sally Jeffries Breakdown of academic impact, for papers by Samuel Quentin
Rankless by CCL
2026